George Simeon
5 of 18 shown
The 5 most recent of 18 visible filings, newest first.
- CRISPR Therapeutics AG Director30,000 sharesOption exercise
- CRISPR Therapeutics AG Director$720,373Open-market sale
- CRISPR Therapeutics AG Director$420,000Option exercise
- ADARx Pharmaceuticals, Inc. Director, 10% owner198,019 sharesConversion
- ADARx Pharmaceuticals, Inc. Director, 10% owner1,953,773 sharesConversion